As of November 2024, Oncolys BioPharma has a market cap of $73.61M. This makes Oncolys BioPharma the world's 22975th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $69.64M | -7.05% |
2023 | $74.93M | 7.59% |
2022 | $69.64M | -0.19% |
2021 | $69.78M | -64.87% |
2020 | $198.63M | -21.84% |
2019 | $254.13M | 85.98% |
2018 | $136.65M | 32.39% |
2017 | $103.21M | -27.62% |
2016 | $142.59M | 67.55% |
2015 | $85.11M | -17.22% |
2014 | $102.81M | -75.73% |
2013 | $423.55M | - |